Methods that can identify subgroups with different trajectories of cognitive decline are crucial for isolating the biologic mechanisms which underlie these groupings.
Objective:
This study grouped older adults based on their baseline cognitive profiles using a latent variable approach and tested the hypothesis that these groups would differ in their subsequent trajectories of cognitive change.
Methods:
In this study we applied time-varying effects models (TVEMs) to examine the longitudinal trajectories of cognitive decline across different subgroups of older adults in the Rush Memory and Aging Project.
Results:
A total of 1,662 individuals (mean age = 79.6 years, SD = 7.4, 75.4%female) participated in the study; these were categorized into five previously identified classes of older adults differing in their baseline cognitive profiles: Superior Cognition (n = 328, 19.7%), Average Cognition (n = 767, 46.1%), Mixed-Domains Impairment (n = 71, 4.3%), Memory-Specific Impairment (n = 274, 16.5%), and Frontal Impairment (n = 222, 13.4%). Differences in the trajectories of cognition for these five classes persisted during 8 years of follow-up. Compared with the Average Cognition class, The Mixed-Domains and Memory-Specific Impairment classes showed steeper rates of decline, while other classes showed moderate declines.
Conclusion:
Baseline cognitive classes of older adults derived through the use of latent variable methods were associated with distinct longitudinal trajectories of cognitive decline that did not converge during an average of 8 years of follow-up.
EdmondsEC, Delano-WoodL, GalaskoDR, SalmonDP, BondiMW (2015) Subtle cognitive decline and biomarker staging in preclinical Alzheimer’s disease. J Alzheimers Dis47, 231–242.
3.
ZammitAR, HallCB, KatzMJ, Muniz-TerreraG, EzzatiA, BennettDA, LiptonRB (2018) Class-specific incidence of all-cause dementia and Alzheimer’s disease: A latent class approach. J Alzheimers Dis66, 347–357.
4.
ZammitAR, HallCB, LiptonRB, KatzMJ, Muniz-TerreraG (2018) Identification of heterogeneous cognitive subgroups in community-dwelling older adults: A latent class analysis of the Einstein Aging Study. J Int Neuropsychol Soc24, 511–523.
5.
LibonDJ, DrabickDA, GiovannettiT, PriceCC, BondiMW, EppigJ, DevlinK, NievesC, LamarM, Delano-WoodL, NationDA, BrennanL, AuR, SwensonR (2014) Neuropsychological syndromes associated with Alzheimer’s/vascular dementia: A latent class analysis. J Alzheimers Dis42, 999–1014.
6.
ClarkLR, Delano-WoodL, LibonDJ, McDonaldCR, NationDA, BangenKJ, JakAJ, AuR, SalmonDP, BondiMW (2013) Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?J Int Neuropsychol Soc19, 635–645.
7.
HaydenKM, ReedBR, ManlyJJ, TommetD, PietrzakRH, CheluneGJ, YangFM, RevellAJ, BennettDA, JonesRN (2011) Cognitive decline in the elderly: An analysis of population heterogeneity. Age Ageing40, 684–689.
8.
EdmondsEC, Delano-WoodL, ClarkLR, JakAJ, NationDA, McDonaldCR, LibonDJ, AuR, GalaskoD, SalmonDP, BondiMW (2015) Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors. Alzheimers Dement11, 415–424.
9.
ZammitAR, BennettDA, HallCB, LiptonRB, KatzMJ, Muniz-TerreraG (2020) A latent transition analysis model to assess change in cognitive states over three occasions: Results from the Rush Memory and Aging Project. J Alzheimers Dis73, 1063–1073.
10.
DavidsonJE, IrizarryMC, BrayBC, WettenS, GalweyN, GibsonR, BorrieM, DelisleR, FeldmanHH, HsiungG-Y, FornazzariL, GauthierS, GuzmanD, Loy-EnglishI, KerenR, KerteszA, George-HyslopPS, WherrettJ, MonschAU (2010) An exploration of cognitive subgroups in Alzheimer’s disease. J Int Neuropsychol Soc16, 233–243.
11.
ZammitAR, Muniz-TerreraG, KatzMJ, HallCB, EzzatiA, BennettDA, LiptonRB (2019) Subtypes based on neuropsychological performance predict incident dementia: Findings from the Rush Memory and Aging Project. J Alzheimers Dis67, 125–135.
12.
Delano-WoodL, BondiMW, SaccoJ, AbelesN, JakAJ, LibonDJ, BozokiA (2009) Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology. J Int Neuropsychol Soc15, 906–914.
13.
ZammitAR, HallCB, BennettDA, EzzatiA, KatzMJ, Muniz-TerreraG, LiptonRB (2019) Neuropsychological latent classes at enrollment and postmortem neuropathology. Alzheimers Dement15, 1195–1207.
14.
Duke HanS, NguyenCP, StrickerNH, NationDA (2017) Detectable neuropsychological differences in early preclinical Alzheimer’s disease: A meta-analysis. Neuropsychol Rev27, 305–325.
15.
ZahodneLB, SchupfN, BrickmanAM, MayeuxR, WallMM, SternY, ManlyJJ (2016) Dementia risk and protective factors differ in the context of memory trajectory groups. J Alzheimers Dis52, 1013–1020.
16.
ZahodneLB, WallMM, SchupfN, MayeuxR, ManlyJJ, SternY, BrickmanAM (2015) Late-life memory trajectories in relation to incident dementia and regional brain atrophy. J Neurol262, 2484–2490.
17.
BennettDA, BuchmanAS, BoylePA, BarnesLL, WilsonRS, SchneiderJA (2018) Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis64, S161–s189.
18.
BennettDA, SchneiderJA, BuchmanAS, BarnesLL, BoylePA, WilsonRS (2012) Overview and findings from the rush Memory and Aging Project. Curr Alzheimer Res9, 646–663.
19.
WilsonRS, Mendes De LeonCF, BarnesLL, SchneiderJA, BieniasJL, EvansDA, BennettDA (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA287, 742–748.
20.
WilsonR, BarnesL, BennettD (2003) Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Neuropsychol25, 634–642.
21.
WilsonRS, BarnesLL, KruegerKR, HogansonG, BieniasJL, BennettDA (2005) Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc11, 400–407.
22.
WechslerD (1987) Wechsler Memory Scale - Revised, The Psychological Corporation, San Antonio.
23.
BuschkeH (1984) Cued recall in amnesia. J Clin Neuropsychol6, 433–440.
24.
MorrisJC, HeymanA, MohsRC, HughesJP, van BelleG, FillenbaumG, MellitsED, ClarkC (1989) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology39, 1159–1165.
25.
KaplanEF, GoodglassH, WeintraubS (1983) The Boston Naming Test, Lea & Febiger, Philadelphia.
26.
WechslerD (1997) Adult Intelligence Scale-III, Psychological Corporation, San Antonio, TX.
27.
WerheidK, HoppeC, ThöneA, MüllerU, MüngersdorfM, von CramonDY (2002) The Adaptive Digit Ordering Test: Clinical application, reliability, and validity of a verbal working memory test. Arch Clin Neuropsychol17, 547–565.
28.
RavenJJ (2003) Raven progressive matrices. In Handbook of Nonverbal Assessment,McCallum RS, ed. Springer, Boston, MA.
SheridanLK, FitzgeraldHE, AdamsKM, NiggJT, MartelMM, PuttlerLI, WongMM, ZuckerRA (2006) Normative Symbol Digit Modalities Test performance in a community-based sample. Arch Clin Neuropsychol21, 23–28.
31.
YangJ, TanX, LiR, WagnerA (2012) TVEM: Time-varying effect model. SAS macro suite users’ guide (version 200). The Methodology Center, Penn State, University Park, PA.
32.
LanzaST, VasilenkoSA, RussellMA (2016) Time-varying effect modeling to address new questions in behavioral research: Examples in marijuana use. Psychol Addict Behav30, 939–954.
33.
HastieT, TibshiraniR (1993) Varying-coefficient models. J R Stat Soc Series B Methodol55, 757–796.
34.
BoylePA, YangJ, YuL, LeurgansSE, CapuanoAW, SchneiderJA, WilsonRS, BennettDA (2017) Varied effects of age-related neuropathologies on the trajectory of late life cognitive decline. Brain140, 804–812.
35.
SpragueBN, PhillipsCB, RossLA (2019) Age-varying relationships between physical function and cognition in older adulthood. J Gerontol B Psychol Sci Soc Sci74, 772–784.
36.
HallCB, YingJ, KuoL, SliwinskiM, BuschkeH, KatzM, LiptonRB (2001) Estimation of bivariate measurements having different change points, with application to cognitive ageing. Stat Med20, 3695–3714.
37.
SliwinskiMJ, HoferSM, HallC (2003) Correlated and coupled cognitive change in older adults with and without preclinical dementia. Psychol Aging18, 672–683.
38.
WilsonRS, BeckettLA, BarnesLL, SchneiderJA, BachJ, EvansDA, BennettDA (2002) Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging17, 179–193.
39.
BangenKJ, ClarkAL, WerhaneM, EdmondsEC, NationDA, EvangelistaN, LibonDJ, BondiMW, Delano-WoodL (2016) Cortical amyloid burden differences across empirically-derived mild cognitive impairment subtypes and interaction with APOE ɛ4 genotype. J Alzheimers Dis52, 849–861.
SchneiderJA, BoylePA, ArvanitakisZ, BieniasJL, BennettDA (2007) Subcortical infarcts, Alzheimer’s disease pathology, and memory function in older persons. Ann Neurol62, 59–66.
42.
SchneiderJA, WilsonRS, CochranEJ, BieniasJL, ArnoldSE, EvansDA, BennettDA (2003) Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology60, 1082–1088.
43.
YangFM, GrigorenkoA, TommetD, FariasST, MungasD, BennettDA, JonesRN, CranePK (2013) AD pathology and cerebral infarctions are associated with memory and executive functioning one and five years before death. J Clin Exp Neuropsychol35, 24–34.
44.
EdmondsEC, EppigJ, BondiMW, LeydenKM, GoodwinB, Delano-WoodL, McDonaldCR, Alzheimer’s Disease Neuroimaging Initiative (2016) Heterogeneous cortical atrophy patterns in MCI not captured by conventional diagnostic criteria. Neurology87, 2108–2116.
45.
WeakleyA, WilliamsJA, Schmitter-EdgecombeM, CookDJ (2015) Neuropsychological test selection for cognitive impairment classification: A machine learning approach. J Clin Exp Neuropsychol37, 899–916.
46.
KaffashianS, DugravotA, ElbazA, ShipleyMJ, SabiaS, KivimäkiM, Singh-ManouxA (2013) Predicting cognitive decline: A dementia risk score vs. the Framingham vascular risk scores. Neurology80, 1300–1306.
47.
KivipeltoM, NganduT, LaatikainenT, WinbladB, SoininenH, TuomilehtoJ (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population-based study. Lancet Neurol5, 735–741.
48.
SindiS, CalovE, FokkensJ, NganduT, SoininenH, TuomilehtoJ, KivipeltoM (2015) The CAIDE Dementia Risk Score App: The development of an evidence-based mobile application to predict the risk of dementia. Alzheimers Dement (Amst)1, 328–333.
49.
ChosyEJ, EdlandSD, GrossN, MeyerMJ, LiuCY, LaunerLJ, WhiteLR (2019) The CAIDE Dementia Risk Score and the Honolulu-Asia Aging Study. Dement Geriatr Cogn Disord48, 164–171.
50.
ArbuthnottK, FrankJ (2000) Trail making test, part B as a measure of executive control: Validation using a set-switching paradigm. J Clin Exp Neuropsychol22, 518–528.
51.
KofmanO, MeiranN, GreenbergE, BalasM, CohenH (2006) Enhanced performance on executive functions associated with examination stress: Evidence from task-switching and Stroop paradigms. Cogn Emotion20, 577–595.
52.
ReitanRM (1958) Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills8, 271–276.
53.
CheluneGJ, BaerRA (1986) Developmental norms for the Wisconsin card sorting test. J Clin Exp Neuropsychol8, 219–228.
54.
BraileanA, HuismanM, PrinceM, PrinaAM, DeegDJH, ComijsH (2018) Cohort differences in cognitive aging in the Longitudinal Aging Study Amsterdam. J Gerontol B Psychol Sci Soc Sci73, 1214–1223.
55.
YuL, PetyukVA, GaiteriC, MostafaviS, Young-PearseT, ShahRC, BuchmanAS, SchneiderJA, PiehowskiPD, SontagRL, FillmoreTL, ShiT, SmithRD, De JagerPL, BennettDA (2018) Targeted brain proteomics uncover multiple pathways to Alzheimer’s dementia. Ann Neurol84, 78–88.
